Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

BNA 2023 and Bna 2023 View overview page

2:01
Modulating the glymphatic system to treat Parkinson’s disease
Ian Harrison • 25 Apr 2023
3:08
Unveiling the molecular mechanisms of cognitive impairment in Duchenne muscular dystrophy
Joanna Pomeroy • 25 May 2023
2:18
Studying mitophagy in Parkinson’s disease with induced dopaminergic neurons
Francesco Capriglia • 25 Apr 2023
12:07
Project T21: unleashing the potential of cannabis-based medicinal products
Anne Schlag • 27 Apr 2023
2:18
Diagnostic challenges in atypical parkinsonian disorders
Boyd Ghosh • 20 Apr 2023
2:36
The challenge of removing established treatments: EVT + IVT
Johanna Ospel • 13 Apr 2023
3:24
Three-month outcomes for patients with chronic pain using cannabis-based medical products
Anne Schlag • 27 Apr 2023
1:26
Seed amplification assays in tauopathies
Boyd Ghosh • 20 Apr 2023
1:29
What are patients’ priorities for MND research?
Jane Haley • 24 Apr 2023
1:31
Exploring the significance of alpha-synuclein post-translational modifications
Tiago Outeiro • 25 Apr 2023
7:14
Advocating for medical cannabis access and acceptance in the UK
Anne Schlag • 27 Apr 2023
1:12
The impact of diet and exercise on adult hippocampal neurogenesis
David Petrik • 25 Apr 2023
1:20
Novel genetic approaches for DMD: addressing immune response challenges
Joanna Pomeroy • 25 Apr 2023
1:59
Addressing unmet needs in MND care
Jane Haley • 24 Apr 2023
1:42
Investigating the relevance of alpha-synuclein localization in synucleinopathies
Tiago Outeiro • 25 May 2023
1:53
Tenecteplase increasingly implemented as standard of care in acute ischemic stroke
Johanna Ospel • 13 Apr 2023
The content of VJNeurology is intended for healthcare professionals